BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21747143)

  • 1. [Current status and future prospects of therapy for myasthenia gravis: considering thymectomy].
    Yoshikawa H; Iwasa K; Takamori M
    Brain Nerve; 2011 Jul; 63(7):729-36. PubMed ID: 21747143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [International project--MGTX study].
    Yoshikawa H
    Rinsho Shinkeigaku; 2007 Nov; 47(11):880-2. PubMed ID: 18210825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone.
    Newsom-Davis J; Cutter G; Wolfe GI; Kaminski HJ; Jaretzki A; Minisman G; Aban I; Conwit R
    Ann N Y Acad Sci; 2008; 1132():344-7. PubMed ID: 18567886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
    Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BRF; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Verschuuren JJGM; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Silvestri NJ; Conwit R; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
    Lancet Neurol; 2019 Mar; 18(3):259-268. PubMed ID: 30692052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Significance of Extended Thymectomy in Non-Thymomatous Myasthenia Gravis: an MGTX Study].
    Yoshikawa H
    Brain Nerve; 2017 Jan; 69(1):51-59. PubMed ID: 28126978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
    Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thymectomy on late-onset myasthenia gravis without thymoma.
    Kawaguchi N; Kuwabara S; Nemoto Y; Fukutake T; Arimura K; Osame M; Hattori T
    Clin Neurol Neurosurg; 2007 Dec; 109(10):858-61. PubMed ID: 17904281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
    Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis.
    Endo S; Yamaguchi T; Saito N; Otani S; Hasegawa T; Sato Y; Sohara Y
    Ann Thorac Surg; 2004 May; 77(5):1745-50. PubMed ID: 15111178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of thymectomy plus prednisone compares with prednisone monotherapy for the treatment of non-thymomatous Myasthenia Gravis: Protocol for a systematic review.
    Yang H; Liu D; Hong X; Sun H; Zheng Y; Yang B; Wang W
    Medicine (Baltimore); 2020 Jun; 99(25):e20832. PubMed ID: 32569233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcome after extended thymectomy combined postoperative high-dose steroid therapy for juvenile myasthenia gravis.
    Kanzaki M; Obara T; Sasano S; Hikawa Y; Onuki T
    Ann Thorac Cardiovasc Surg; 2008 Apr; 14(2):119-22. PubMed ID: 18414352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis.
    Zhu K; Li J; Huang X; Xu W; Liu W; Chen J; Chen P; Feng H
    Neurol Sci; 2017 Oct; 38(10):1753-1760. PubMed ID: 28707128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of thymectomy in patients with Myasthenia Gravis.
    Al-Mahdawi AM; Al-Talib NM
    Saudi Med J; 2002 Jan; 23(1):39-43. PubMed ID: 11938362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete stable remission after extended transsternal thymectomy in myasthenia gravis.
    Park IK; Choi SS; Lee JG; Kim DJ; Chung KY
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):525-8. PubMed ID: 16857374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis.
    Huang CS; Hsu HS; Huang BS; Lee HC; Kao KP; Hsu WH; Huang MH
    Acta Neurol Scand; 2005 Aug; 112(2):108-14. PubMed ID: 16008537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis with thymoma and autoimmune haemolytic anaemia. A case report.
    Tuncer Elmaci N; Ratip S; Ince-Günal D; Tanridağ T
    Neurol Sci; 2003 Apr; 24(1):34-6. PubMed ID: 12754655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurologic outcomes of thymectomy in myasthenia gravis: comparative analysis of the effect of thymoma.
    Kim HK; Park MS; Choi YS; Kim K; Shim YM; Han J; Kim BJ; Kim J
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):601-7. PubMed ID: 17723805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trans-sternal thymectomy in myasthenia gravis].
    Inderbitzi R; Rösler K; Nachbur B
    Chirurg; 1991 Jun; 62(6):474-8. PubMed ID: 1914644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Trial of Thymectomy in Myasthenia Gravis.
    Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
    N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.